Latest Posts

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

OUR PIPELINE

With our partners in Biotech and Pharma we have built a track record of 32+ successful drug discovery and development partnerships at multiple stages of maturity, clinical development and market readiness. Together with our partners we drive therapeutics programs through all relevant inflection points independent of disease  area and therapeutic modality.
Therapeutic Area Indication Target Stage Partner
Oncology Solid tumors AKAP-4 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
Oncology Pancreatic cancer PI3K Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Oncology Multiple oncology indications MetAP2 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Multiple oncology indications OX40 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Pancreatic cancer Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Oncology and Inflammatory diseases Confidential PIM family Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
Immunology Multiple immunology indications IL-17 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Neurodegenerative diseases Alzhiemers disease Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
Mental health disorders Depression Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Anxiety Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Sleep disorder Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders ADHD Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Opoid abuse Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Schizophrenia Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Sensori-neural diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Metabolic diseases T1D and co-morbidities Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Cardiology Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology + others Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Infectious diseases Antimicrobial resistance Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
Infectious diseases Covid-19 3CLPro Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Pain related indications Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
ICU treatment Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Multiple TAs Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Oncology Solid tumors AKAP-4 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
Oncology Pancreatic cancer PI3K Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Oncology Multiple oncology indications MetAP2 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Multiple oncology indications OX40 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Oncology Pancreatic cancer Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Oncology and Inflammatory diseases Confidential PIM family Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
Therapeutic Area Indication Target Stage Partner
Immunology Multiple immunology indications IL-17 Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Inflammatory disorders Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Therapeutic Area Indication Target Stage Partner
Neurodegenerative diseases Alzhiemers disease Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
Mental health disorders Depression Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Anxiety Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Sleep disorder Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders ADHD Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Opoid abuse Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Mental health disorders Schizophrenia Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Sensori-neural diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Metabolic diseases T1D and co-morbidities Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Cardiology Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Therapeutic Area Indication Target Stage Partner
Dermatology + others Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Dermatology Confidential TLR Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Therapeutic Area Indication Target Stage Partner
Infectious diseases Antimicrobial resistance Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
Infectious diseases Covid-19 3CLPro Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
Pain related indications Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
ICU treatment Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
Therapeutic Area Indication Target Stage Partner
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Rare diseases Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
Multiple TAs Confidential Confidential Pre – Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
LINK_TEXT_HERE

    Innoplexus needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

    LINK_TEXT_HERE
    Therapeutic Area Indication Target Stage Partner
    Oncology Solid tumors AKAP-4 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
    Oncology Pancreatic cancer PI3K Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
    Oncology Multiple oncology indications MetAP2 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
    Oncology Multiple oncology indications OX40 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
    Oncology Pancreatic cancer Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Oncology and Inflammatory diseases Confidential PIM family Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
    Immunology Multiple immunology indications IL-17 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
    Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Neurodegenerative diseases Alzhiemers disease Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
    Mental health disorders Depression Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Anxiety Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Sleep disorder Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders ADHD Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Opoid abuse Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Schizophrenia Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Sensori-neural diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Metabolic diseases T1D and co-morbidities Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Cardiology Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Dermatology + others Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Infectious diseases Antimicrobial resistance Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
    Infectious diseases Covid-19 3CLPro Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
    Pain related indications Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    ICU treatment Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Multiple TAs Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Therapeutic Area Indication Target Stage Partner
    Oncology Solid tumors AKAP-4 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Verik bio
    Oncology Pancreatic cancer PI3K Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
    Oncology Multiple oncology indications MetAP2 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
    Oncology Multiple oncology indications OX40 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
    Oncology Pancreatic cancer Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Oncology and Inflammatory diseases Confidential PIM family Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Inflection Biosciences
    Therapeutic Area Indication Target Stage Partner
    Immunology Multiple immunology indications IL-17 Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Cureteq
    Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Inflammatory disorders Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Therapeutic Area Indication Target Stage Partner
    Neurodegenerative diseases Alzhiemers disease Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio alpha
    Mental health disorders Depression Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Anxiety Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Sleep disorder Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders ADHD Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Opoid abuse Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Mental health disorders Schizophrenia Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Sensori-neural diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Therapeutic Area Indication Target Stage Partner
    Metabolic diseases T1D and co-morbidities Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Cardiology Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Therapeutic Area Indication Target Stage Partner
    Dermatology + others Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Dermatology Confidential TLR Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Therapeutic Area Indication Target Stage Partner
    Infectious diseases Antimicrobial resistance Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Discoveric bio beta
    Infectious diseases Covid-19 3CLPro Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Land of Hessen
    Pain related indications Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    ICU treatment Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch DrD
    Therapeutic Area Indication Target Stage Partner
    Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Rare diseases Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential
    Multiple TAs Confidential Confidential Pre - Discovery Discovery Pre-Clinical Clinical Launch Post-Launch Confidential